Oncology Institute authorizes up to 2M share repurchase at ≤$1.00; Deerfield consents

Oncology Institute, Inc.

Board approved repurchase of up to 2M shares of common stock at price not exceeding $1.00 per share.
Limited Consent with Deerfield permits repurchases on or before Sep 16, 2023 under same price cap.
Repurchased shares will be returned to authorized but unissued status.
Company not obligated to repurchase any shares; timing subject to market conditions.
Limited Consent also grants one-time waiver of certain notice requirements under Facility Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.